Abbott Laboratories (ABT) Scheduled to Post Earnings on Wednesday
Abbott Laboratories (NYSE:ABT) is scheduled to be posting its quarterly earnings results on Wednesday, January 22nd. Individual interested in listening to the company’s earnings conference call can do so using this link.
Shares of Abbott Laboratories (NYSE:ABT) opened at 39.40 on Tuesday. Abbott Laboratories has a one year low of $32.55 and a one year high of $39.86. The stock’s 50-day moving average is $38.13 and its 200-day moving average is $36.2. The company has a market cap of $60.920 billion and a P/E ratio of 20.67.
A number of analysts have recently weighed in on ABT shares. Analysts at Cowen and Company raised their price target on shares of Abbott Laboratories from $41.00 to $45.00 in a research note to investors on Friday. On the ratings front, analysts at Morgan Stanley upgraded shares of Abbott Laboratories from an “equal weight” rating to an “overweight” rating in a research note to investors on Friday. They now have a $45.00 price target on the stock. Finally, analysts at Jefferies Group raised their price target on shares of Abbott Laboratories from $48.00 to $49.00 in a research note to investors on Thursday, January 9th. They now have a “buy” rating on the stock. One investment analyst has rated the stock with a sell rating, seven have given a hold rating and eight have issued a buy rating to the stock. The company has a consensus rating of “Hold” and a consensus target price of $39.64.
Abbott Laboratories (NYSE:ABT), is engaged in the discovery, development, manufacture, and sale of a portfolio of science-based health care products.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.